CapeOx -HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A multicenter propensity score-matched analysis

Surgical Oncology 2026

View at publisher
Authors: Ming Yao, Liying Lu, Yangyang Ou, Chenyi Zhuo, Guandou Yuan, Yonglian Zeng, Liang Liang, Junjiang Guo, Yiyu Chen, Xiaoyong Cai, Yihe Yan, Jianjun Li
+1 more Songqing He
DOI: 10.1016/j.suronc.2026.102392
Cited by: 1
References: 25

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Cancer Mechanisms and Therapy Ferroptosis and cancer prognosis

Publication details

Journal / source
Surgical Oncology
Publisher
Elsevier BV
Volume
65
Pages
102392–102392
Publication date
26 February 2026
Language
EN